The Union Cabinet on 30 October 2013 approved the five years
Pharmaceuticals Purchase Policy (PPP). The PPP renewal has been approved
to ensure finest utilization of the installed capacity of pharma of the
Central Public Sector Enterprises (CPSEs).
As per the policy, 103 medicines were validated for five years from
the date of the issue of the orders by the Department of
Pharmaceuticals. The pricing of the products would be done by the
National Pharmaceutical Pricing Authority (NPPA) following the cost
based formulae, as per the Drugs Price Control Order. Uniform discount
of 16 percent on all products would be available.
The policy extended only to the Central Public Sector Enterprises
(CPSEs) under the administrative control of Department of
Pharmaceuticals, like the Hindustan Antibiotics, Indian Drugs and
Pharmaceuticals, Karnataka Antibiotics and Pharmaceuticals, Rajasthan
Drugs and Pharmaceuticals and Bengal Chemicals and Pharmaceuticals along
with and their subsidiaries, where Governments holds minimum of 51
percent or more shares.
In the year 2006, the Cabinet approved the same type of policy for
102 medicines which are manufactured by the PSUs that expired in the
year 2011.
No comments:
Post a Comment